Pharmaceuticals News and Research

RSS

Cambrex wins the CPhI Innovation Award for its Continuous-Flow Microwave-Assisted Organic Synthesis technology

Cambrex Corporation announced today that it won the Silver Innovation Award at the 2009 CPhI Event for its Continuous-Flow Microwave-Assisted Organic Synthesis (CFMAOS) technology. The award was accepted by Dr. Jayne E. Muir (Market Research & New Technologies - Europe), who presented the technology to a panel of judges at this important pharmaceutical ingredients exhibition in Madrid, Spain on October 13, 2009.

21 Oct 2009

IMS Health to retain Foros Securities as its financial advisor

IMS Health, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced that it is exploring a variety of strategic alternatives. The Company further stated that as part of the process the Board of Directors has formed a committee, which has retained Foros Securities LLC as its financial advisor.

21 Oct 2009

MediWound reports positive results from phase III Debrase trial for treating burns

Teva Pharmaceutical Industries Ltd. announced today that MediWound Ltd., a company in which Teva holds an 11% interest, reported positive results from a pre planned interim analysis of a phase III trial for Debrase®, an enzymatic debriding agent for burns.

21 Oct 2009

Osteologix to continue clinical development of NB S101 osteoporosis drug

Osteologix, Inc., a bio-pharmaceutical company announced today that the company will continue the clinical development for its osteoporosis drug, NB S101 (strontium malonate), in the United States and the rest of the world markets. Additionally, the company wants to recognize World Osteoporosis Day’s significance and make more people aware of its research dedicated to improving the lives of people with osteoporosis.

21 Oct 2009

Apotex to market Hisamitsu's Fentanyl Transdermal System for chronic pain management

Apotex Corp announced today that it has signed an exclusive distribution agreement with Hisamitsu Pharmaceutical Company of Japan. Apotex will sell to the U.S. healthcare market, Hisamitsu's recently FDA approved matrix Fentanyl Transdermal System for the management of chronic pain.

21 Oct 2009

Also in Global Health News: Cholera in Zimbabwe; personal computers; medical 'outliers'; rain in Kenya; generic drugs

A cholera outbreak in Zimbabwe has infected more than 100, resulting in five deaths, state media said Tuesday, Reuters reports, "raising fears of a repeat of last year's epidemic that claimed more than 4,000 lives.

21 Oct 2009

Simcere and OSI Pharmaceuticals to market KDR/Kit inhibitor OSI-930 in China

Simcere Pharmaceutical Group ("Simcere" or the "Company"), a leading pharmaceutical company specializing in development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced an agreement with OSI Pharmaceuticals, Inc., to develop, manufacture, and market its KDR/Kit inhibitor OSI-930 in China.

21 Oct 2009

U.S. patent for Celsis IVT's LiverPool products

Celsis International is pleased to announce that the United States Patent and Trademark Office today issued U.S. Patent No. 7,604,929 to Celsis In Vitro Technologies (Celsis IVT). This patent generally covers processes by which the company creates its unique LiverPool(TM) products for drug discovery research.

20 Oct 2009

Positive results from KAI Pharmaceuticals' pain therapeutic program

KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, announced positive preclinical results from its program targeting the gamma protein kinase C (PKC) pathway for the development of novel therapies for pain.

20 Oct 2009

Tarsa Therapeutics receives license for Phase III oral calcitonin program

Unigene Laboratories, Inc. and Tarsa Therapeutics, Inc. today announced that Unigene has licensed its Phase III oral calcitonin program to Tarsa, a new company formed by a syndicate of three venture capital funds specializing in the life sciences: MVM Life Science Partners, Quaker BioVentures and Novo A/S.

20 Oct 2009

Positive data from BioSante Pharmaceuticals' LibiGel Phase III clinical development program

BioSante Pharmaceuticals, Inc., today announced positive safety data in its ongoing LibiGel Phase III clinical development program. For the first time, unblinded data have been reviewed by the independent DMC of the LibiGel Cardiovascular and Breast Cancer Safety Study. Based on this review of unblinded data, the DMC unanimously recommended continuation of the study as described in the study protocol, with no modifications.

20 Oct 2009

Targacept presents data from Phase 2b clinical trial of TC-5214

Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics-, today announced the presentation of data from its recently completed Phase 2b clinical trial of TC-5214 as an augmentation (add-on) treatment in subjects with major depressive disorder, or MDD, who did not respond adequately to first-line treatment with the representative SSRI citalopram hydrobromide.

20 Oct 2009

Boehringer Ingelheim continues providing non assert declarations to manufacture HIV/AIDS medicines

Boehringer Ingelheim continues to be willing to provide WHO qualified generic pharmaceutical companies non assert declarations to manufacturer and export products containing the HIV/AIDS medication nevirapine to Rwanda and other defined developing countries.

20 Oct 2009

Meeting to discuss latest information on anti-aging medicine and euthanasia

America's foremost authorities on aging will share the latest information on "death panels," anti-aging medicine, health care reform, and other current topics at The Gerontological Society of America's upcoming 62nd Annual Scientific Meeting. This four day event - the country's largest interdisciplinary conference in the field of aging - will take place from November 18 to 22 in Atlanta, GA. Media representatives can register free of charge.

20 Oct 2009

Unitedhealth announces third quarter results; reports growth in revenues and net earnings

UnitedHealth Group reported third quarter results today, including growth in revenues and net earnings and a continued strong financial position.

20 Oct 2009

USP offers redesigned pharmaceutical standards format to improve key documentation process

To improve key documentation relied upon by the pharmaceutical industry and others, the U.S. Pharmacopeial (USP) Convention announces the release of the redesigned United States Pharmacopeia-National Formulary (USP-NF).

20 Oct 2009

A.P. Pharma to raise funds through placement

A.P. Pharma, a specialty pharmaceutical company, today announced it has entered into a definitive securities purchase agreement with certain existing accredited investors providing for a private placement of up to $13.1 million in two tranches, the first consisting of common stock and warrants with aggregate proceeds of approximately $8.1 million, and a second tranche of common stock with proceeds of approximately $5 million.

20 Oct 2009

Waters presents a new video on its UPLC Systems, Mass Spectrometers and SDMS software solutions

Waters Corporation has posted a new version of its online video showcase featuring compelling interviews with more than 50 scientists, development partners, and product experts in the fields of pharmaceutical discovery and development, food safety, environmental analysis, sports medicine, disease research and clinical toxicology and clinical research.

20 Oct 2009

PhRMA calls for appropriate incentives for continued biotechnology innovation

Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today regarding appropriate incentives for continued biotechnology innovation:

20 Oct 2009

Preliminary findings from EDC survey presented at DIA 3rd Annual Clinical Forum

Preliminary findings from a new survey on electronic data capture (EDC) use in clinical trials were presented today at the Drug Information Association's (DIA) 3rd Annual Clinical Forum in Nice, France. The survey, titled "Investigational Site Perspectives on Clinical Trial Information Systems," is the first update to a 2001 survey published on the topic.

20 Oct 2009

Pharmaceuticals News and Research

Cambrex wins the CPhI Innovation Award for its Continuous-Flow Microwave-Assisted Organic Synthesis technology

IMS Health to retain Foros Securities as its financial advisor

MediWound reports positive results from phase III Debrase trial for treating burns

Osteologix to continue clinical development of NB S101 osteoporosis drug

Apotex to market Hisamitsu's Fentanyl Transdermal System for chronic pain management

Also in Global Health News: Cholera in Zimbabwe; personal computers; medical 'outliers'; rain in Kenya; generic drugs

Simcere and OSI Pharmaceuticals to market KDR/Kit inhibitor OSI-930 in China

U.S. patent for Celsis IVT's LiverPool products

Positive results from KAI Pharmaceuticals' pain therapeutic program

Tarsa Therapeutics receives license for Phase III oral calcitonin program

Positive data from BioSante Pharmaceuticals' LibiGel Phase III clinical development program

Targacept presents data from Phase 2b clinical trial of TC-5214

Boehringer Ingelheim continues providing non assert declarations to manufacture HIV/AIDS medicines

Meeting to discuss latest information on anti-aging medicine and euthanasia

Unitedhealth announces third quarter results; reports growth in revenues and net earnings

USP offers redesigned pharmaceutical standards format to improve key documentation process

A.P. Pharma to raise funds through placement

Waters presents a new video on its UPLC Systems, Mass Spectrometers and SDMS software solutions

PhRMA calls for appropriate incentives for continued biotechnology innovation

Preliminary findings from EDC survey presented at DIA 3rd Annual Clinical Forum

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring